Napiórkowska-Mastalerz, M.; Wybranowski, T.; Bosek, M.; Kruszewski, S.; Rhone, P.; Ruszkowska-Ciastek, B.
A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study. Cancers 2024, 16, 1068.
https://doi.org/10.3390/cancers16051068
AMA Style
Napiórkowska-Mastalerz M, Wybranowski T, Bosek M, Kruszewski S, Rhone P, Ruszkowska-Ciastek B.
A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study. Cancers. 2024; 16(5):1068.
https://doi.org/10.3390/cancers16051068
Chicago/Turabian Style
Napiórkowska-Mastalerz, Marta, Tomasz Wybranowski, Maciej Bosek, Stefan Kruszewski, Piotr Rhone, and Barbara Ruszkowska-Ciastek.
2024. "A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study" Cancers 16, no. 5: 1068.
https://doi.org/10.3390/cancers16051068
APA Style
Napiórkowska-Mastalerz, M., Wybranowski, T., Bosek, M., Kruszewski, S., Rhone, P., & Ruszkowska-Ciastek, B.
(2024). A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study. Cancers, 16(5), 1068.
https://doi.org/10.3390/cancers16051068
